Article Sidebar
Published:
Sep 6, 2024DOI:
10.4314/tjpr.v23i7.7Keywords:
Article Details
Submission of a manuscript to this journal is a representation that the manuscript has not been published previously and is not under consideration for publication elsewhere.
All authors named in each manuscript would be required to sign a form (to be supplied by the Editor) so that they may retain their copyright in the article but to assign to us (the Publishers) and its licensees in perpetuity, in all forms, formats and media (whether known or created in the future) to (i) publish, reproduce, distribute, display and store the contribution, (ii) translate the contribution into other languages, create adaptations, reprints, include within collections and create summaries, extracts and/or abstracts of the contribution, (iii) create any other derivative works(s) based on the contribution, (iv) to exploit all subsidiary rights in the contribution, (v) the inclusion of electronic links from the contribution to third party material where-ever it may be located, and (vi) license any thrid party to do any or all of the above.
Main Article Content
Knowledge of pharmacists in Saudi Arabia on the use of topical corticosteroids in atopic dermatitis
Abstract
Purpose: To investigate pharmacists’ knowledge and sources of information, as well as identify future interventions concerning the use of topical corticosteroids for the treatment of atopic dermatitis.
Methods: This was a cross-sectional study involving a survey of pharmacists practicing in the Kingdom of Saudi Arabia from March 2022 to July 2022 using a self-structured questionnaire. Categorical responses were presented in frequency and percentages. Measurement data were presented as mean ± standard deviation (SD), and differences were compared using Pearson chi-square. P < 0.05 was considered statistically significant.
Results: A total of 288 pharmacists participated in the survey; out of these, 79 % of pharmacists provided incorrect answers, believing that topical corticosteroids (TCS) are used to cure eczema/dermatitis. Mean score of overall knowledge was 10.13 (2.9) while 54.9 % showed poor knowledge of TCS, and 45.1 % had adequate knowledge. Furthermore, pharmacists who were nonSaudi indigenes, senior pharmacists and those having master's degrees had significantly higher knowledge scores than others.
Conclusion: Knowledge of TCS for treating atopic dermatitis among pharmacists in Saudi Arabia is poor. There is a significant association of knowledge with being a non-Saudi indigene, pharmacist’s rank, qualification, area of practice, and additional training. Promoting continuous education and implementing formal undergraduate training programs would address this knowledge gap and ultimately improve pharmacists' understanding of topical corticosteroid use in atopic dermatitis.
